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Tuberculosis (TB), caused by the organism Mycobacterium tuberculosis, 
remains a major global health burden and is responsible for ill health 
among millions of people each year. It is currently the leading cause of 
death as a result of a single infectious agent worldwide.[1] South Africa 
(SA) has a reported TB incidence of 567/100 000 cases per year.[1] The 
reported incidence of TB in the Nelson Mandela Bay district, Eastern 
Cape Province, SA, is 1 009/100 000 cases per year,[2] which is much 
higher than the national average. In the Eastern Cape, it is reported 
to be the leading cause of death in persons 25 - 64 years of age.[2] 
Unfortunately SA, where the treatment cure rate is 82%, is failing at 
a national level to reach the proposed World Health Organization 
(WHO) target of 90%.[1] 
Patients who receive dialysis are particularly vulnerable to 
active TB infection compared with the general population, due 
to immune dysfunction induced by their uraemic state.[3-5] In 
other low- and middle-income countries (LMICs), the incidence 
of TB among prevalent dialysis patients is 6.9 - 52.5 times higher 
than in the general population, depending on regional factors and 
background prevalence.[6-8] Other factors that might contribute to 
decreased immunity are malnutrition, vitamin D deficiency and 
hyperparathyroidism.[9]
There is a paucity of data regarding the incidence of TB in 
SA dialysis patients, where the background population prevalence 
is among the highest in the world. We are aware of only one 
published single-centre SA study by Tamayo-Isla et al.,[10] conducted 
in Polokwane, Limpopo Province, SA, where the authors describe 
a high mortality rate associated with TB peritonitis in continuous 
ambulatory peritoneal dialysis (CAPD) patients. 
Objectives 
To determine the incidence of TB in chronic kidney disease stage 5 
(CKD-5D) patients receiving dialysis at a single centre in the Eastern 
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Background. Tuberculosis (TB) is currently the leading cause of death from a single infectious agent worldwide. Patients who receive 
dialysis are particularly vulnerable to TB infection owing to immune dysfunction. Nonetheless, there is a paucity of incidence data on 
dialysis patients infected with TB in high-burden countries, such as South Africa (SA). 
Objectives. To determine the incidence of TB in prevalent chronic kidney disease stage 5 (CKD-5D) patients on dialysis at a single centre 
in Eastern Cape Province, SA, and to identify the risk factors associated with TB infection.
Methods. We conducted a retrospective cohort study of all consenting CKD-5D patients between April 2010 and March 2014 at Livingstone 
Hospital Renal Unit, Port Elizabeth, the Eastern Cape. TB was defined as definite or probable according to World Health Organization 
(WHO) criteria, and the cohort was split into those who developed TB (TB+) and those who did not (TB−). 
Results. One hundred and eleven patients were enrolled – predominantly black Africans (73%) and women (53%); the mean age (standard 
deviation (SD)) was 42 (9.8) years. The prevalence of HIV infection was 11%, all patients were receiving antiretroviral treatment and all had 
suppressed viral loads. Sixty-eight patients were on haemodialysis and 43 on peritoneal dialysis. Nineteen patients were diagnosed with 
20 episodes of TB; 14 cases were pulmonary TB and 6 cases extrapulmonary TB. Of the patients with TB, 2 were HIV-infected, 7 (35%) were 
definite TB cases and 13 (65%) were probable cases. The calculated incidence rate was 4 505/100 000 patient years. Only informal housing 
(30% in TB+ v. 12% in TB−; p=0.042) and a history of hospitalisation (90% v. 76%, respectively; p=0.042) were significantly associated with 
a diagnosis of TB.
Conclusions. Dialysis patients in the Eastern Cape region of SA are at extremely high risk of acquiring TB, with an incidence rate 4.1 times 
that of the local population and >5 times that of the general SA population. Only informal housing and a history of hospitalisation were 
identified as positive risk factors for TB in this young population with a low HIV prevalence. Isoniazid prophylaxis in this high-risk group 
might be of benefit, but further studies are required to inform such treatment.
S Afr Med J 2020;110(5):422-426. https://doi.org/10.7196/SAMJ.2020.v110i5.14035
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Cape, SA, and to identify modifiable and non-modifiable risk factors 
associated with TB. 
Methods
Study design 
We conducted a retrospective cohort study of all consenting prevalent 
CKD-5D patients between April 2010 and March 2014 in the Livingstone 
Hospital Renal Unit in the Eastern Cape. A total of 111 consent ing 
prevalent dialysis patients were enrolled in the study during the 4-year 
period; no patient had TB at enrolment. 
Data collection
TB was defined as definite or probable according to WHO criteria.[11] 
Definite TB patients were defined as those in whom TB complex 
was identified from a clinical specimen by culture or newer methods, 
including line-probe assays. Probable TB patients were those with 
constitutional symptoms, radiological features suggestive of TB 
and/or caseating granulomas on histological examination, but with no 
positive culture identification of TB.[11] A medical questionnaire with 
all the required data was used. Patient demographics, including dialysis 
vintage, age, gender, race (self-reported), employment status, smoking, 
alcohol use, history of hospitalisation for any cause during the study 
period but prior to enrolment, housing type and TB household contact 
status were recorded. Details regarding the diagnosis of TB, mean time 
between initiation of dialysis and diagnosis, HIV status, vitamin D 
level, comorbidities and medications were also recorded. 
Statistical analysis
The estimated incidence was calculated as the percentage of patients 
who developed TB during the study period. This incidence was then 
converted into an incidence per 100 000 divided by 4 (for the 4 years) 
to give an estimated incidence per 100 000 per year of study period.
Normality was determined with the Shapiro-Wilk test. Continuous 
variables were expressed as mean (standard deviation (SD)), while 
categorical variables were presented as frequencies and percentages. 
Univariate analysis was performed using the independent Student’s t-test, 
χ2 test or Wilcoxon rank-sum test, as appropriate. All analyses were 
conducted using Stata 12.0 (StataCorp., USA).
Ethical approval
The study was approved by the Human Research Ethics Committee 
of the University of Cape Town, SA (ref. no. HREC/REF 127:2014), 
and permission for conducting the study was obtained from local 
authorities.
Results
Baseline characteristics of patients, including gender, HIV status, 
prior use of immunosuppressives, employment, smoking, known TB 
contact status and dialysis modality, are presented in Table 1. A total 
of 111 patients were enrolled, predominantly black Africans (73%) 
and women (53%); their mean age (SD) was 42.1 (9.8) years. The 
prevalence of HIV infection was 11%, and all patients were receiving 
antiretroviral treatment. Sixty-eight patients received haemodialysis 
and 43 peritoneal dialysis; 93% were unemployed. 
The characteristics of patients with TB are shown in Table 2. 
Nineteen (18%) patients were diagnosed with TB over the 4-year 
study period, with 1 patient treated for TB on two occasions (#6 and 
#7, Table 2), giving a total of 20 TB cases; 14 patients had pulmonary 
and 6 extrapulmonary TB. Of the 20 TB patients (Fig. 1), 7 (35%) 
were definite TB cases and 13 (65%) had probable TB. Of the 7 defi-
nite cases, 1 patient (#5) had TB peritonitis with dialysate effluent 
culture positive for drug-sensitive TB; 2 patients (#7 and #11) had 
TB adenitis and culture-confirmed drug-sensitive TB; 1 patient (#1) 
had disseminated TB with a miliary pattern on a chest radiograph, a 
Table 1. Baseline characteristics of TB+ and TB− dialysis patients
Variables Patients (N=111), %* TB+ (n=19), %* TB− (n=92), %* p-value
Age, mean (years) 42 42.4 41.8 0.868
Gender
Female 53 45 55 0.396
Employment status
Unemployed 93 90 93 0.584
Smoking status
≥10 pack-years 16 10 18 0.405
<10 pack-years 84 90 82 0.405
Hospitalisation 79 90 76 0.042
Housing
Brick 85 70 88 0.042
Shack 15 30 12 0.042
Use of biomass fuel 8 5 8.7 0.582
TB contact 28 40 25 0.174
HIV status 
Positive 11 10 11 0.909
Use of immunosuppression 8 1.4 6.6 0.171
Vitamin D, nmol/L 
Deficiency and insufficiency 45.7 20.8 79.2 0.800
Dialysis modality
Haemodialysis 61 18 82 0.898
Peritoneal dialysis 39 19 81 0.898
TB = tuberculosis; TB+ = developed TB; TB− = did not develop TB.
*Unless otherwise indicated.
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bone marrow biopsy showing caseating granulomas and a mycolytic 
blood culture that confirmed drug-sensitive TB; 1 patient (#9) had 
drug-resistant TB (multidrug-resistant TB (MDR-TB)) on culture; 
1 (#12) had pulmonary TB with positive acid-fast bacilli on sputum 
microscopy (culture was not available), and 1 (#13) had pulmonary 
TB (suggestive chest radiograph) and was positive for drug-sensitive 
TB on sputum culture.
Of the 13 probable TB patients, 10 were diagnosed based on clinical 
features and lymphocytic pleural effusion and 2 had pericardial 
effusions with stranding on echocardiography. A pericardial tap in 
both patients revealed a lymphocyte-predominant picture, while 1 patient 
had a miliary pattern on chest radiography but a negative culture. The 
incidence of TB infection is shown in Fig. 2.
Discussion 
This single-centre retrospective cohort study revealed an extra-
ordinarily high incidence of TB in dialysis patients in the Eastern 
Cape, with a calculated incidence 4.1 times that of the local population 
and >5 times that reported in the general population for the country 
as a whole (Fig. 2). While such a relative risk is consistent with that 
described in dialysis cohorts from other countries,[8] the absolute risk 
to our TB patients is extremely high given the very high background 
prevalence of TB in SA (~1 in 5 over a 5-year period). The patients are 
predominantly young and HIV-negative, reflecting the selection bias 
in the SA public sector dialysis programme that favours those with 
less comorbidity. Moosa and Kidd[14] have previously reported on 
Table 2. Demographics and clinical characteristics of TB patients 
Patient Gender Age, years Race
Time on 
dialysis, 
months* HIV status
Dialysis 
modality TB infection Definite/probable
1 Female 52 Black 4 Negative HD Bone marrow Definite
2 Female 44 Black 63 Negative HD Pleural effusion Probable
3 Female 39 Black 3 Positive HD Pleural effusion Probable
4 Female 35 Mixed 0 Negative PD Pleural effusion Probable
5 Male 34 Black 16 Negative PD Peritoneal fluid Definite
6 Female 59 Black 12 Negative HD Pulmonary Probable
7 Female 59 Black 12 Negative HD TB adenitis Definite
8 Male 38 Black 56 Positive HD Pleural effusion Probable
9 Female 53 Black 38 Negative HD Pulmonary Definite
10 Female 50 Mixed 50 Negative PD TB pericarditis Probable
11 Male 34 Mixed 72 Negative PD TB adenitis Definite
12 Male 45 Black 35 Negative HD Pleural effusion Definite
13 Male 56 Black 32 Negative HD Pulmonary Definite
14 Male 43 Black 19 Negative PD Pleural effusion Probable
15 Male 31 Black 2 Negative PD TB pericarditis Probable
16 Male 28 Mixed 13 Negative PD Miliary Probable
17 Female 41 Mixed 44 Negative HD Pleural effusion Probable
18 Male 35 Black 37 Negative HD Pleural effusion Probable
19 Male 38 Black 59 Negative HD Pleural effusion Probable
20 Male 41 Black 49 Negative PD Pleural effusion Probable
TB = tuberculosis; HD = haemodialysis; PD = peritoneal dialysis.
*Duration of dialysis before TB diagnosis.
Pulmonary TB
Miliary TB
TB pericarditis
TB adenitis
TB peritonitis
Bone marrow
n=13
n=1
n=1
n=1
n=2
n=2
Fig. 1. TB-positive cases: spread of TB diagnosis. (TB = tuberculosis.)
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Fig. 2. Tuberculosis incidence in the study population compared with the 
local, regional and national incidence in 2015.[12,13] 
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the rationing of dialysis treatment in SA – patients are screened and 
accepted onto the dialysis programme based on favourable medical 
and socioeconomic criteria. Known TB risk factors that we assessed 
included age, employment status, smoking, alcohol use, average 
number of days admitted to hospital per year, housing type, TB 
contact status, HIV status and vitamin D levels.[15,16] However, of these 
risk factors, only informal housing and a history of hospitalisation 
were significantly associated with a diagnosis of TB (p≤0.05). In SA, 
informal housing (shack dwelling) is associated with overcrowding 
and unhygienic conditions, which would favour the transmission 
of TB in the community. While a history of hospitalisation may 
represent a more compromised cohort prone to TB, lack of adequate 
isolation facilities in our hospital during the study period may have 
contributed to nosocomial transmission of TB, although this is 
speculative. 
Interestingly, HIV was not predictive of TB, but this is possibly 
confounded by the use of isoniazid (INH) chemoprophylaxis therapy 
in this group according to national guidelines and the low overall 
prevalence of HIV in our unit (11%). Moreover, all HIV patients on 
dialysis had undetectable viral loads and relatively preserved CD4+ 
counts as per dialysis selection criteria discussed above. A higher 
number of patients with TB had a history of a known TB contact 
(40% v. 25%), but this was not statistically significant (p=0.174). The 
combined vitamin D deficiency/insufficiency prevalence for our 
cohort was 45.7% and was not shown to be a significant risk factor for 
the development of TB. However, vitamin D levels were not measured 
at the time of TB diagnosis, as the test has not always been available 
at our study centre. 
In our study, the incidence of extrapulmonary TB was very high 
(30%) and is consistent with reports from previous studies of CKD 
patients.[8,11,17-20] The increased tendency for extrapulmonary TB in 
CKD patients is thought to be due to impaired cellular immunity.[19] 
In dialysis patients, TB symptoms are often nonspecific and difficult 
to distinguish from uraemic symptoms, which can result in delayed 
diagnosis.[8,19] This may also facilitate transmission to other patients, 
particularly in haemodialysis units, where patients spend much time 
in close proximity to each other. Of the 20 TB patients, 7 (35%) were 
definite cases, with positive microscopy or culture. Tamayo-Isla et al.,[10] 
in their retrospective TB peritonitis study in SA, reported that TB was 
isolated in 75% of their cohort. In our cohort, 13/20 (65%) patients 
with TB were culture negative, reflecting the difficulty of definitive 
TB diagnosis in dialysis patients.
INH chemoprophylaxis in HIV-positive patients has been found 
to be efficacious in a number of large-scale randomised controlled 
trials, with up to a 74% reduction in TB incidence in select groups 
displaying a positive tuberculin skin test.[21] There are clear guidelines 
for this population, but data on INH chemoprophylaxis in CKD 
patients are lacking. A few randomised clinical trials have assessed 
INH chemoprophylaxis in both pre- and post-transplant patients 
and demonstrated its benefit to such patients for up to 1 year.[22-24] 
Further large randomised clinical studies in the dialysis setting are 
required to help inform best practice regarding when to commence 
INH chemoprophylaxis and the most efficacious duration of therapy.
Study limitations and strengths
There were some limitations to the study. Because of its retrospective 
nature, we were unable to include dialysis patients who had died 
during the study period, as their health records were unavailable. We 
also could not make assumptions regarding hospitalisation as a risk 
factor for TB, as we could not prove causality. Details regarding the 
reason for admission, length of stay and timing in relation to onset of 
TB were not available. 
Study strengths include use of a single laboratory with 
standardised methodology, as well as availability of accurate clinical 
notes for determination of the diagnosis. While the overall numbers 
are relatively low for this cohort, a further strength of this study is 
that it included all living patients on dialysis in the public sector 
for the entire western part of the Eastern Cape and is therefore 
inclusive.
Conclusions
Dialysis patients in the Eastern Cape are at extremely high risk for 
TB, with a calculated incidence of 4 505/100  000 population per 
year. There is a need for improved healthcare structures, including 
the provision of adequate isolation facilities for TB patients in our 
hospital and renal unit to reduce transmission. Further research on 
outcomes and response to TB treatment of CKD patients in SA is 
required. Whether INH prophylaxis is a reasonable option for TB 
prevention in this population, remains unknown and should be the 
subject of further study.
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